FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
40 letters match. Newest first.
-
DrugsChongqing Qiancan Technology Co., Ltd.
Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.
High risk -
DrugsTianjin Healthcare Medical Technology Co., Ltd.
Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.
High risk -
DrugsGuangdong Bisutang Biotechnology Co., Ltd.
Guangdong Bisutang Biotechnology refused FDA records requests for OTC drugs and used a cancelled color additive in sunscreen.
High risk -
DrugsYangzhou Hongshengding Chemical Co., Ltd.
Yangzhou Hongshengding Chemical refused FDA records requests for its over-the-counter drugs, leading to an import alert.
High risk -
DrugsRevlon Group Holdings, LLC
FDA cited Revlon's Oxford, NC over-the-counter drug plant for failing to test talc for asbestos and weak quality oversight.
High risk -
DrugsZydus Lifesciences Limited
FDA warns Zydus Lifesciences over untested asbestos in talc used in its prescription drugs and altered lab data at its Himachal Pradesh plant.
High risk -
DrugsAeroflex Industria de Aerosol Ltda.
Brazil OTC drug maker Aeroflex ignored FDA records requests, prompting possible approval holds and US shipment refusals.
High risk -
DrugsHangzhou Yiqi Biotechnology Co., Ltd
FDA cited Hangzhou Yiqi Biotechnology, an API maker in China, for four manufacturing practice failures found in a records review.
High risk -
DevicesUnomedical Device S.A. de C.V.
FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.
High risk -
DrugsMedia Networks Sydney Pty. Limited
FDA says Australia's Media Networks Sydney failed to answer drug records requests for OTC Combantrin Chocolate Squares.
High risk -
BiologicsCellebration LLC
FDA warns Cellebration LLC over unapproved cord-blood cellular products and refusal to provide requested records.
High risk -
DrugsYangzhou Yulou Paper Products Co., Ltd.
FDA cited Yangzhou Yulou Paper Products for manufacturing violations after records showed its OTC sterile drugs lacked sterility assurance and testing.
High risk -
DrugsSterling Distributors
FDA warned Florida drug wholesaler Sterling Distributors for shipping prescription drugs without licenses and ignoring a counterfeit report.
High risk -
DrugsNingbo Riway Industrial Co., Ltd.
Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.
High risk -
DrugsZenzi Pharmaceutical Industries Pvt. Ltd.
Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.
High risk -
DrugsAkron Formulations India Private Limited
Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.
High risk -
BiologicsMother Stem Institute, Corp.
FDA warns Mother Stem Institute over unapproved fat-derived SVF 'stem cell' biologic marketed for serious diseases.
High risk -
DrugsZen Enterprises LLC
Zen Enterprises failed to correct drug listing files that named a manufacturer not involved in making its balms and hand sanitizers.
Low -
DrugsWipro Unza Singapore Private, Limited
FDA cites Wipro Unza Singapore for refusing OTC hand sanitizer records, leading to import alert.
High risk -
DrugsSaruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi
FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.
High risk -
DrugsHygienic Labs, LLC
Hygienic Labs, an OTC drug manufacturer, failed to respond to FDA records requests.
Medium -
DrugsZhao Qing Longda Biotechnology Co. Ltd.
FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.
High risk -
DrugsGulf States International, Inc.
Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.
Medium -
DrugsMaison Blanche LLC
FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.
Medium -
DrugsCergomex Imports, LLC
Cergomex Imports, an over-the-counter drug manufacturer, refused FDA records requests for its Sanetto Hands Sanitizer Gel.
Medium -
DrugsGTP International Corp
GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.
Medium -
DrugsKM Pharmaceutical Co. Ltd.
FDA says KM Pharmaceutical refused to provide drug records and placed all its drugs on import alert.
High risk -
DrugsSangleaf Pharm., Co. Ltd.
Sangleaf Pharm failed to give FDA requested records for OTC drugs, including children's toothpaste, at risk of DEG/EG contamination.
High risk -
DrugsSkyline Herbals Private Limited
FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.
High risk -
DrugsDaxal Cosmetics Private Limited
FDA warns Daxal Cosmetics for refusing records on over-the-counter drugs, including toothpaste, at risk for diethylene glycol and ethylene glycol contamination.
High risk -
DrugsChengdu KeCheng Fine Chemicals Co., Ltd.
FDA placed Chengdu KeCheng's APIs on import alert after it ignored FDA records requests.
High risk -
DrugsChampaklal Maganlal Homeo Pharmacy Private Limited
FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.
High risk -
DrugsChemical Services Group, Inc./Royal Chemical Company
Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.
High risk -
DrugsClean Cosmetics LLC
FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.
High risk -
DrugsThe Anthos Group, Inc.
Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.
Medium -
DrugsGuangzhou Orchard Aromatherapy & Skin Care Co., Ltd.
Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.
High risk -
DrugsHealthMEDS Inc.
HealthMEDS Inc., an over-the-counter drug maker, failed to provide FDA-requested records and did not respond to repeated FDA contacts.
Medium -
DrugsTrue Chemical Solutions, LLC
FDA cites True Chemical Solutions over unanswered hand sanitizer records requests.
Medium -
DrugsNanomateriales QuĂmicos Avanzados, S.A. de C.V.
FDA found Mexican maker Nanomateriales' ZANILAST hand sanitizer labeled 65% ethanol contained 1-propanol, with quality and labeling violations.
High risk -
DrugsFurley Bioextracts SDN BHD
FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.
High risk